September 2026
The global in vitro diagnostics quality controls market size is estimated to hit around USD 2,713.92 million by 2035, increasing from USD 1,736.17 million in 2026, with a CAGR of 5.09%.
September 2026
The global in vitro diagnostics (IVD) market size accounted for USD 106.16 billion in 2026 and is expected to reach USD 135.76 billion by 2035.
August 2026
The us in vitro diagnostics market reached USD 35.94 billion in 2026, featuring leading us in vitro diagnostics companies such as alere inc, Beckman coulter, bd, Danaher, Bio-Rad laboratories.
September 2026
The infectious disease in-vitro diagnostics market size is valued at USD 28.78 billion in 2026 and is expected to hit around USD 35.68 billion by 2035, growing at a CAGR of 2.42%.
November 2025
The in-vitro diagnostics enzymes market size is evaluated at USD 2.49 billion in 2025 and is expected to attain around USD 4.58 billion by 2035 with a CAGR of 6.28%
July 2025
The global in-vitro inflammatory bowel disease diagnostics market size was valued at USD 1.74 billion in 2024 and is expected to hit around USD 3.02 billion by 2034, at a CAGR of 5.64%.
September 2026
The global guillain barre syndrome diagnostics market size is estimated to hit around USD 206.70 million by 2035 increasing from USD 158.64 million in 2026, with a CAGR of 2.99%.
September 2026
The global in-vitro fertilization market size is expected to increase from USD 34.97 billion in 2026 to hit around USD 73.09 billion by 2035, with a CAGR of 8.57%.
September 2026
The global point-of-care infectious disease diagnostics market size is projected to hit around USD 25.66 billion by 2035, with a CAGR of 15.26% from 2026 to 2035.
September 2026
The global non-invasive cancer diagnostics market size is projected to hit around USD 350.78 billion by 2035 from USD 185.94 billion in 2026, with a CAGR of 7.32%.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
September 2026
The global point-of-care diagnostics market size is exhibited at USD 65.94 billion in 2026 and is predicted to be worth around USD 85.03 billion by 2035 with a CAGR of 2.87%.
September 2026
The global infectious disease molecular diagnostics market size is estimated to hit around USD 63.37 billion by 2034 with a CAGR of 3.25% from 2026 to 2034.
September 2026
The global cardiac AI monitoring and diagnostics market size was evaluated at USD 5.17 billion in 2026 and is predicted to hit around USD 18.89 billion by 2035, growing at a CAGR of 15.48%.
September 2026
The artificial intelligence in diagnostics market size was calculated at USD 2.33 billion in 2026 and is projected to hit around USD 11.82 billion by 2035 with a CAGR of 19.81%.
September 2026
The in-vitro colorectal cancer screening tests market size is projected to surge around USD 1,310 million by 2034 from USD 1030 million in 2026, with a CAGR of 3.05%.
August 2026
The global tissue diagnostics market size is expected to increase from USD 5.77 billion in 2025 and is projected to hit around USD 10.99 billion by 2035 with a CAGR of 6.66%
July 2026
The global point-of-care molecular diagnostics market size was valued at USD 8.95 billion in 2025 and is expected to hit around USD 13.06 billion by 2035, at a CAGR of 3.85%.
June 2026
The global veterinary point of care diagnostics market size is estimated to hit around USD 7.87 billion by 2035 from USD 3.27 billion in 2026, with a CAGR of 10.27%.
June 2026
The global veterinary diagnostics market size is estimated to hit around USD 30.47 billion by 2035 increasing from USD 13.02 billion in 2026, with a CAGR of 9.92%.
March 2026
The global infectious disease diagnostics market size is expected to reach around USD 71.06 billion by 2035 from USD 35.39 billion in 2025 with a CAGR of 7.22%.
February 2026
The in-vitro toxicology testing market size was valued at USD 12.99 billion in 2025 and is expected to hit around USD 36.42 billion by 2035, growing at a CAGR of 10.86%.
September 2026
The rapid diagnostics market size was estimated at USD 61.75 billion in 2026 and is projected to surpass around USD 322.71 billion in 2035 with a solid CAGR of 20.23%.
September 2026
The precision diagnostics market size was estimated at USD 109.84 billion in 2026, with precision diagnostics market Companies Abbott Laboratories, Bayer AG, Koninklijke Philips N.V., Lantheus Holdings Inc.
September 2026
The global PCR-based transplant diagnostics market size is estimated to hit around USD 1,286.31 million by 2035 increasing from USD 703.8 million in 2026, with a CAGR of 6.93%.
September 2026
The global advanced vehicle diagnostics and remote services market size was evaluated at USD 8.95 billion in 2026 and is predicted to hit around USD 24.28 billion by 2035, growing at a CAGR of 11.73%.
September 2026
The global food diagnostics market size is calculated at USD 20.64 billion in 2026 and is projected to hit around USD 36.75 billion by 2035 with a CAGR of 6.63%.
September 2026
The preeclampsia diagnostics market size reached USD 1.33 billion in 2026, with leading preeclampsia diagnostics market companies including Thermo Fisher Scientific, F. Hoffmann La Roche Ltd, PerkinElmer Inc.
September 2026
The global saliva collection and diagnostics market size is valued at USD 899.03 million in 2026 and is expected to hit around USD 1,363.13 million by 2035, with a CAGR of 4.73%.
September 2026
The homecare diagnostics & therapeutics market size accounted for USD 291.51 billion in 2026 and is expected to hit USD 577.56 billion by 2035, with a CAGR of 7.90%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com